Free Trial
Fall Lock-In Sale! MarketBeat All Access, $149 a Year for Life
Lock In $149
Claim MarketBeat All Access Sale Promotion
NASDAQ:QSI

Quantum-Si Q3 2026 Earnings Date & Estimates

Quantum-Si logo
$1.46 +0.06 (+4.29%)
Closing price 04:00 PM Eastern
Extended Trading
$1.47 +0.01 (+0.62%)
As of 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Quantum-Si is estimated to report Q3 2026 earnings on Thursday, November 5, 2026, after market closes. The conference call is scheduled for 4:30 PM ET.

Upcoming Earnings Announcement

Quarter
Q3 2026
Announcement Date
Time
After Market Closes
Conference Call
4:30 PM ET

What Analysts Expect from Quantum-Si in Q3 2026

Quantum-Si is expected to post earnings of -$0.13 per share on revenue of $268 thousand. In the same quarter a year earlier Quantum-Si reported -$0.17 per share on revenue of $552 thousand. Quantum-Si last reported on August 13, 2026, posting -$0.11 per share and beating the -$0.1133 consensus estimate. Quantum-Si has beaten the consensus EPS estimate in 6 of its last 8 quarters.

Consensus Estimates

Consensus EPS
-$0.13
Expected Revenue
$268 thousand
Prior-Year EPS
-$0.17
Prior-Year Revenue
$552 thousand
Expected Revenue Growth
-51.4%

Recent Track Record

Last Reported
Q2 2026
Last Quarter EPS
-$0.11 (Beat by +$0.0033)
Last Quarter Revenue
$344 thousand
EPS Beat Rate
6 of last 8 quarters

Quantum-Si Q3 2026 Earnings FAQ

Quantum-Si (NASDAQ:QSI) is estimated to report Q3 2026 earnings on Thursday, November 5, 2026, after market closes. This date is estimated from past reporting schedules and may change once the company confirms it.

Quantum-Si's Q3 2026 earnings conference call is scheduled for Thursday, November 5, 2026 at 4:30 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect Quantum-Si to post earnings of -$0.13 per share for Q3 2026.

The consensus revenue estimate for Quantum-Si is $268 thousand for Q3 2026.

Quantum-Si Earnings Headlines

Quantum-Si (NASDAQ:QSI) Rating Lowered to "Sell" at Wall Street Zen
My next big call (under $1)
17,556% on KDA. 3,900% on PRE. 2,650% on OCEAN. Every single one of these was recommended to our community before the big move happened. Now, I'm making my next big call. It's a coin under $1.00 that most investors have never heard of. But the world's largest bank is already building on it. It has a deflationary burn mechanism tied directly to institutional usage. With Bitcoin well off its highs and fear still hanging over the market, this is the exact environment where my biggest winners have been found.tc pixel
See More Quantum-Si Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Quantum-Si? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Quantum-Si and other key companies, straight to your email.

About Quantum-Si

Quantum-Si (NASDAQ:QSI) (NASDAQ:QSI) is a life sciences technology company focused on transforming protein analysis through next-generation proteomics. The company develops tools designed to identify and characterize proteins at the single-molecule level, with potential applications in drug discovery, translational research, diagnostics development and precision medicine.

Its primary offering is the Platinum platform, which combines a benchtop sequencing instrument, semiconductor-based technology, consumables and data-analysis software. The platform is designed to provide researchers with protein sequencing and identification capabilities using a scalable workflow. Quantum-Si also offers related assay kits, reagents and software intended to support sample preparation, instrument operation and analysis of proteomic data.

Quantum-Si was founded by technology entrepreneur Jonathan Rothberg and became a publicly traded company in 2021 through a business combination with HighCape Capital Acquisition Corp. The company is headquartered in Guilford, Connecticut, and serves academic, pharmaceutical, biotechnology and other research customers through its commercial operations and distribution channels.

View Quantum-Si Profile